4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-23-006529
Chief Business Officer acquired 107,202 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Martin Michael Robert Chief Business Officer | 2023-03-02 | Grant or award | +107,202 | 259,162 | D |
Loading xslF345X03/wf-form4_167813811794255.xml…